HLA-DQ同种抗体直接激活内皮并损害FoxP3high调节性T淋巴细胞分化
本研究探讨HLA-DQ同种抗体如何调节内皮激活和免疫调节。HLA-DQ抗体通过Akt依赖方式磷酸化微血管内皮细胞Akt和S6激酶,增加IL-6和RANTES分泌,并选择性减少T细胞同种增殖和FoxP3high Treg分化。临床检测显示HLA-DQ DSAs与其他DSAs共存时移植物存活更差。
要点
- HLA-DQ抗体直接激活微血管内皮细胞,上调IL-6和RANTES分泌。
- HLA-DQ抗体选择性抑制FoxP3high Treg分化,损害免疫调节。
- HLA-DQ DSAs与其他DSAs共存时移植物存活更差。
核心结论
- HLA-DQ抗体单独或与其他HLA抗体协同促进促炎反应,提示其致病性。
研究设计与样本
- 体外研究:患者HLA-DQ同种抗体处理微血管内皮细胞,与同种反应性淋巴细胞共培养;临床研究分析DSAs与移植物存活关联。
主要发现
- HLA-DQ抗体磷酸化微血管内皮细胞Akt和S6激酶。
- HLA-DQ抗体上调IL-6和RANTES分泌,且IL-6上调依赖Akt。
- HLA-DQ抗体选择性减少T细胞同种增殖和FoxP3high Treg分化。
- HLA-DQ DSAs与其他DSAs共存时移植物存活差于单独存在。
- HLA-DR和HLA-DQ抗体刺激内皮细胞协同增加促炎因子分泌并减少Treg扩增。
临床怎么用
- 监测HLA-DQ DSAs可能有助于评估肾移植排斥风险,尤其与其他DSAs共存时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Development of donor-specific antibodies is associated with reduced allograft survival in renal transplantation. Recent clinical studies highlight the prevalence of human leukocyte antigen (HLA)-DQ antibodies amongst de novo donor-specific antibodies (DSAs), yet the specific contribution of these DSAs to rejection has not been examined. Antibody-mediated rejection primarily targets the microvasculature, so this study explored how patient HLA-DQ alloantibodies can modulate endothelial activation and so immunoregulation. HLA-DQ antibodies phosphorylated Akt and S6 kinase in microvascular endothelial cells. This activation prior to culture with alloreactive lymphocytes increased IL-6 and RANTES secretion. The antibody-mediated upregulation of IL-6 was indeed Akt-dependent. The binding of HLA-DQ antibodies to endothelial cells selectively reduced T cell alloproliferation and FoxP3high Treg differentiation. In clinical studies, detection of HLA-DQ DSAs with other DSAs is associated with worse graft survival than either alone. Endothelial cells stimulated with HLA-DR and HLA-DQ antibodies showed a synergistic increase in pro-inflammatory cytokine secretion and a decrease in Treg expansion. HLA-DQ antibodies strongly promote pro-inflammatory responses in isolation and in combination with other HLA antibodies. Thus, our data give new insights into the pathogenicity of HLA-DQ DSAs.
引用
- Cross AR, Lion J, Poussin K, et al. HLA-DQ alloantibodies directly activate the endothelium and compromise differentiation of FoxP3high regulatory T lymphocytes. Kidney Int. 2019. PMID: 31307777. doi:10.1016/j.kint.2019.04.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。